Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new statement has been released from Professor Peter Horby and Professor Martin Landray, Chief Investigators of the RECOVERY Trial. RECOVERY was established in March as a randomised clinical trial to test a range of potential drugs for COVID-19, including hydroxycholoroquine. The trial has proceeded at unprecedented speed, enrolling over 11,000 patients from 175 NHS hospitals in the UK. The chief investigators have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with COVID-19.

Pills in a petri dish, in front of a microscope

The coronaviral landscape across diverse mammalian species in the Northeastern United States

Journal article

Ibemgbo S. et al, (2026), Scientific Reports, 16

Seasonal dynamics and control of malaria: A non-autonomous model incorporating vaccination and drug resistance

Journal article

Onah IS., (2026), Nonlinear Analysis: Real World Applications, 91, 104584 - 104584

A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam

Journal article

Thi HN. et al, (2026), International Journal of Infectious Diseases, 168, 108673 - 108673

Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025

Journal article

Dhawan S. et al, (2026), Journal of Infection, 93, 106766 - 106766

A case of gastrointestinal tuberculosis in a 3-mo-old infant with profound immunodeficiency.

Journal article

Karanja-Chege C. et al, (2026), Journal of human immunity, 2

Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda.

Journal article

Maitland K. et al, (2026), N Engl J Med

Transmission of rifampicin-resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective genomic epidemiology study

Journal article

Walker T. et al, (2026), The Lancet Regional Health. Western Pacific

Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccines

Journal article

Arman BY. et al, (2026), International Journal of Pharmaceutics: X, 11, 100467 - 100467

Assessing transporter‐mediated rifampin–linezolid interaction using physiologically‐based pharmacokinetic modelling

Journal article

Nguyen HD. et al, (2026), British Journal of Clinical Pharmacology, 92, 1845 - 1856

Advancing the concept of community positive health through participatory research in marginalized communities in Kenya

Journal article

Peters LER. et al, (2026), Social Science & Medicine, 398, 119147 - 119147

Load More